Why the study?
To highlight the most important studies published in the European Heart Journal-Cardiovascular Imaging during 2021 focusing on valvular heart disease, heart failure, cardiomyopathies, and congenital heart disease.
Design
Review
Highlights 2021 valvular and heart failure imaging studies; leaves open translation to practice pending prospective trials.
The European Heart Journal-Cardiovascular Imaging was launched in 2012 and has during these years become one of the leading multimodality cardiovascular imaging journals. The journal is currently ranked as Number 19 among all cardiovascular journals. It has an impressive impact factor of 9.130. The most important studies published in our Journal from 2021 will be highlighted in two reports. Part II will focus on valvular heart disease, heart failure, cardiomyopathies, and congenital heart disease, while Part I of the review has focused on studies about myocardial function and risk prediction, myocardial ischaemia, and emerging techniques in cardiovascular imaging.
No takes yet. Share an insight, caveat, or question.
Cosyns et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: